Below are some Nursing Education Resources, highlighting online programs.
 

As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health is the state’s leading authority on cancer. As such, we want to help our patients navigate and better understand how the coronavirus may impact them. 

Dr. Gulhati received a Bachelor of Science in Physiology (Honors) from The University of British Columbia. As an undergraduate, he performed research in the laboratory of Dr. Poul Sorensen to identify novel interaction partners of the chimeric oncoprotein, ETV6-NTRK3, which is implicated in cancers of varying lineages. He subsequently completed Physician-Scientist training in the combined MD/PhD program at The University of Texas.

View all of Dr. Gulhati's publications here.

Jackie Harris
Research Administrative Assistant
harrisja@cinj.rutgers.edu

The Gulhati lab is focused on basic and translational research in gastrointestinal cancers. Ongoing projects in the lab are focused on:

Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive and lethal malignancy that will soon be the second leading cause of cancer death and remains remarkably resistant to all forms of therapy. There is a pressing need to gain a deeper understanding of the fundamental biology underlying this recalcitrant disease and uncover novel treatment strategies with sustained therapeutic efficacy.